1RH2 Recombinant Human Interferon-Alpha 2b-01.png
In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses.

Describes the medication interferon (Roferon-A, Intron-A, Rebetron, Alferon-N, Peg-Intron, Avonex, Betaseron, Infergen, Actimmune, Pegasys), a drug used in managing many diseases that involve the immune system.

Interferon Alpha in Systemic Lupus Erythematosus


BioMed Research International is a peer-reviewed, Open Access journal that publishes original research articles as well as review articles in several areas of life sciences. The journal’s Editorial Board is divided into the 55 subject areas included within the journal’s scope.|By Hindawi

Anti-interferon alpha treatment in SLE

Anifrolumab, an Anti-Interferon Antibody, Curbs Lupus Disease Activity

After years of clinical trial failures, early evidence suggests an anti-interferon antibody, anifrolumab, reduces disease activity in systemic lupus…